Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients

Clinical trial NCT07614646 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07614646
Sponsor: Everest Medicines (Beijing) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Non-Small Cell Lung Cancer sqNSCLC

Start date: 2026-07-01
Primary completion: 2028-07-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.